A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
Synonyms :
Class :
may have an increased hypoglycemic effect when combined with meglitinides
may have an increased hypoglycemic effect when combined with meglitinides
may have an increased hypoglycemic effect when combined with meglitinides
may have an increased hypoglycemic effect when combined with meglitinides
may have an increased hypoglycemic effect when combined with meglitinides
may have an increased hypoglycemic effect when combined with meglitinides
may have an increased hypoglycemic effect when combined with meglitinides
CYP3A strong enhancers of the small intestine may reduce the bioavailability of repaglinide 
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
may increase the hypoglycaemic effect
repaglinide: they may diminish the serum concentration of CYP3A4 Inducers
repaglinide: they may diminish the serum concentration of CYP3A4 Inducers
repaglinide: they may diminish the serum concentration of CYP3A4 Inducers
repaglinide: they may diminish the serum concentration of CYP3A4 Inducers
repaglinide: they may diminish the serum concentration of CYP3A4 Inducers
It may enhance toxicity when combined with cholic acid by diminishing the elimination
CYP2C8 Inhibitors: they may enhance the serum concentration of repaglinide
CYP2C8 Inhibitors: they may enhance the serum concentration of repaglinide
CYP2C8 Inhibitors: they may enhance the serum concentration of repaglinide
CYP2C8 Inhibitors: they may enhance the serum concentration of repaglinide
When halometasone is used together with repaglinide, this leads to elevated risk or seriousness of hyperglycemia
When repaglinide is used together with ouabain, this leads to reduction in repaglinide excretion
aminohippuric acid may reduce the excretion of repaglinide
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
may enhance the hypoglycemic effect of antidiabetic agents
it decreases the effect of antidiabetic drugs
may increase the hypoglycaemic effect
It may enhance the risk of adverse effects when combined with Radipharmaceuticals
It may enhance the risk of adverse effects when combined with Radipharmaceuticals
It may enhance the risk of adverse effects when combined with Radipharmaceuticals
It may enhance the risk of adverse effects when combined with Radipharmaceuticals
It may enhance the risk of adverse effects when combined with Radipharmaceuticals
the anti-diabetic efficacy of repaglinide can be reduced with mometasone furoate